Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial. - Li R; Shah PH; Stewart TF; Nam JK; Bivalacqua TJ; Lamm DL; Uchio EM; Geynisman DM; Jacob JM; Meeks JJ; Dickstein R; Pearce SM; et al. (Nature medicine, 2024)